We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$571M
AUM Growth
+$64.7M
(+13%)
Cap. Flow
+$77M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$35.4M |
| 2 |
Stellantis
STLA
|
+$22.2M |
| 3 |
PepsiCo
PEP
|
+$18M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$6.64M |
| 5 |
Kohl's
KSS
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$21.5M |
| 2 |
iShares MSCI Indonesia ETF
EIDO
|
+$11.1M |
| 3 |
Eaton
ETN
|
+$4.76M |
| 4 |
Delta Air Lines
DAL
|
+$4.4M |
| 5 |
Western Union
WU
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.66% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Consumer Staples | 8.41% |
| 4 | Energy | 8.01% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Opko Health
OPK
$993M
| $82K | 0.01% |
+33,621
| New | +$73.4K |
|
352
McKesson
MCK
$101B
| $81.7K | 0.01% |
608
-31,271
| -98% | -$3.9M |
|
353
Encompass Health
EHC
$11B
| $80.7K | 0.01% |
1,601
| – | – |
|
354
Prologis
PLD
$136B
| $77.5K | 0.01% |
968
+153
| +19% | +$11.6K |
|
355
Simon Property Group
SPG
$74.7B
| $77K | 0.01% |
482
| – | – |
|
356
BioMarin Pharmaceuticals
BMRN
$11.7B
| $76.9K | 0.01% |
898
+1
| +0.1% | +$86 |
|
357
DXC Technology
DXC
$1.82B
| $76.5K | 0.01% |
1,388
-55,880
| -98% | -$3.23M |
|
358
Thor Industries
THO
$3.95B
| $76.5K | 0.01% |
1,309
-94
| -7% | -$5.7K |
|
359
Orthofix Medical
OFIX
$477M
| $73.7K | 0.01% |
1,395
| – | – |
|
360
iShares MSCI Chile ETF
ECH
$1.02B
| $71K | 0.01% |
1,738
+633
| +57% | +$26.2K |
|
|
TRQ
361
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $70.4K | 0.01% |
5,683
+5,667
| +35,419% | +$78.4K |
|
362
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
| $69.9K | 0.01% |
2,000
+810
| +68% | +$24.7K |
|
363
Equity Residential
EQR
$25.2B
| $69.5K | 0.01% |
916
-701
| -43% | -$53.5K |
|
|
IPG
364
DELISTED
Interpublic Group of Companies
IPG
| $67.8K | 0.01% |
3,003
+2,898
| +2,760% | +$64.4K |
|
365
AngloGold Ashanti
AU
$41.6B
| $66.3K | 0.01% |
+3,723
| New | +$50K |
|
366
Logitech
LOGI
$14.6B
| $65.2K | 0.01% |
1,631
-17,232
| -91% | -$672K |
|
367
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.35B
| $63.4K | 0.01% |
1,505
| – | – |
|
368
Wheaton Precious Metals
WPM
$51.5B
| $62.7K | 0.01% |
2,592
-313
| -11% | -$6.94K |
|
369
Emerson Electric
EMR
$83.3B
| $62.5K | 0.01% |
937
-54,099
| -98% | -$3.62M |
|
370
Oxford Square Capital
OXSQ
$151M
| $62.3K | 0.01% |
9,733
| – | – |
|
371
Becton Dickinson
BDX
$45.6B
| $62.2K | 0.01% |
+253
| New | +$58.8K |
|
|
ABMD
372
DELISTED
Abiomed Inc
ABMD
| $61.5K | 0.01% |
+236
| New | +$62.6K |
|
|
ORTX
373
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $60.3K | 0.01% |
+431
| New | +$75.7K |
|
374
Blue Bird Corp
BLBD
$2.36B
| $60.3K | 0.01% |
+3,062
| New | +$56.1K |
|
375
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $60.1K | 0.01% |
2,307
-24,483
| -91% | -$635K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2019 Portfolio in Review
As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.
- Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
- Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
- Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
- Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
- Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
- Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
- Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.